Effects of fermented skim milk drink by Kluyveromyces marxianus LAF4 co-cultured with lactic acid bacteria to release angiotensin-converting enzyme inhibitory activities

International Journal of Dairy Technology

Volumn 71, Issue , 2018, Pages 130-140

  Ahtesh, Fatah B ^a   Apostolopoulos, Vasso ^a   Stojanovska, Lily ^a   Shah, Nagendra P ^b   Mishra, Vijay Kumar ^a  

^a VICTORIA UNIVERSITY   (Australia)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Angiotensin converting enzyme; Lactic acid bacteria; Yeast

Indexed keywords

EID: 85025068408     PISSN: 1364727X     EISSN: 14710307     Source Type: Journal    
DOI: 10.1111/1471-0307.12425     Document Type: Article

References (55)

1. Abbas C (2006) Production of antioxidants, aromas, colours, flavours, and vitamins by yeasts. In Yeasts in Food and Beverages, 1st edn, pp. 285–334. Querol A, Fleet G, eds. Berlin, Heidelberg: Springer.
2. Ahtesh F B, Stojanovska L, Mathai M L, Apostolopoulos V and Mishra V K (2016a) Proteolytic and angiotensin-converting enzyme-inhibitory activities of selected probiotic bacteria. International Journal of Food Science & Technology 51 865–874.
3. ® on angiotensin-converting enzyme inhibitory peptides formed in skim milk and whey protein concentrate during fermentation by Lactobacillus helveticus. Journal of Food Science 81 M135–M143.
4. Algaron F, Miranda G, Le Bars D and Monnet V (2004) Milk fermentation by Lactococcus lactis with modified proteolytic systems to accumulate potentially bio-active peptides. Le Lait 84 115–123.
5. Banat I M, Nigam P and Marchant R (1992) Isolation of thermotolerant, fermentative yeasts growing at 52 & #xB0;C and producing ethanol at 45 & #xB0;C and 50 & #xB0;C. World Journal of Microbiology & Biotechnology 8 259–263.
6. Belem M A F and Lee B H (1998) Production of bioingredients from Kluyveromyces marxianus grown on whey: an alternative. Critical Reviews in Food Science and Nutrition 38 565–598.
7. Belem M A F and Lee B H (1999) Fed-batch fermentation to produce oligonucleotides from Kluyveromyces marxianus grown on whey. Process Biochemistry 34 501–509.
8. Belem M A F, Gibbs B F and Lee B H (1999) Proposing sequences for peptides derived from whey fermentation with potential bioactive sites. Journal of Dairy Science 82 486–493.
9. Büchl N R and Seiler H (2011) Yeasts and molds: yeasts in milk and dairy products A2. In Encyclopedia of Dairy Sciences, 2nd edn, pp. 744–753. Fuquay J W, ed. San Diego, CA: Academic Press.
10. Chaves-López C, Paparell A, Tofalo R and Suzzi G (2011a) Proteolytic activity of Saccharomyces cerevisiae strains associated with Italian dry-fermented sausages in a model system. International Journal of Food Microbiology 150 50–58.
11. Chaves-López C, Serio A, Martuscelli M, Paparella A, Osorio-Cadavid E and Suzzi G (2011b) Microbiological characteristics of kumis, a traditional fermented Colombian milk, with particular emphasis on enterococci population. Food Microbiology 28 1041–1047.
12. Chaves-López C, Tofalo R, Serio A, Paparella A, Sacchetti G and Suzzi G (2012) Yeasts from Colombian Kumis as source of peptides with angiotensin I converting enzyme (ACE) inhibitory activity in milk. International Journal of Food Microbiology 159 39–46.
13. Chaves-López C, Serio A, Paparella A, Martuscelli M, Corsetti A, Tofalo R and Suzzi G (2014) Impact of microbial cultures on proteolysis and release of bioactive peptides in fermented milk. Food Microbiology 42 117–121.
14. Church F C, Swaisgood H E, Porter D H and Catignani G L (1983) Spectrophotometric assay using o-phthaldialdehyde for determination of proteolysis in milk and isolated milk proteins. Journal of Dairy Science 66 1219–1227.
15. Didelot S, Bordenave-Juchereau S, Rosenfeld E, Piot J-M and Sannier F (2006) Peptides released from acid goat whey by a yeast-lactobacillus association isolated from cheese microflora. Journal of Dairy Research 73 163–170.
16. Donkor O N, Henriksson A, Singh T K, Vasiljevic T and Shah N P (2007) ACE-inhibitory activity of probiotic yoghurt. International Dairy Journal 17 1321–1331.
17. Erdos E G (1975) Angiotensin I converting enzyme. Circulation Research 36 247–255.
18. Fatah B A (2016) Anti-Hypertensive (Angiotensin Converting Enzyme-Inhibitory) Peptides Released from Milk Proteins by Proteolytic Microorganisms and Enzymes. Australia: Victoria University.
19. Fitzgerald R J and Murray B A (2006) Bioactive peptides and lactic fermentations. International Journal of Dairy Technology 59 118–125.
20. Fonseca G G, Heinzle E, Wittmann C and Gombert A K (2008) The yeast Kluyveromyces marxianus and its biotechnological potential. Applied Microbiology and Biotechnology 79 339–354.
21. Fonseca G G, De Carvalh N M B and Gombert A K (2013) Growth of the yeast Kluyveromyces marxianus CBS 6556 on different sugar combinations as sole carbon and energy source. Applied Microbiology and Biotechnology 97 5055–5067.
22. Fragasso G, Maranta F, Montanaro C, Salerno A, Torlasco C and Margonato A (2012) Pathophysiologic therapeutic targets in hypertension: a cardiological point of view. Expert Opinion on Therapeutic Targets 16 179–193.
23. García-Tejedor A, Padilla B, Salom J B, Belloch C and Manzanares P (2013) Dairy yeasts produce milk protein-derived antihypertensive hydrolysates. Food Research International 53 203–208.
24. Gonzalez-Gonzalez C R, Tuohy K M and Jauregi P (2011) Production of angiotensin-I-converting enzyme (ACE) inhibitory activity in milk fermented with probiotic strains: effects of calcium, pH and peptides on the ACE-inhibitory activity. International Dairy Journal 21 615–622.
25. Hamme V, Sannier F, Piot J-M, Didelot S and Bordenave-Juchereau S (2009) Crude goat whey fermentation by Kluyveromyces marxianus and Lactobacillus rhamnosus: contribution to proteolysis and ACE inhibitory activity. Journal of Dairy Research 76 152–157.
26. Hartmann R and Meisel H (2007) Food-derived peptides with biological activity: from research to food applications. Current Opinion in Biotechnology 18 163–169.
27. Hernández-Ledesma B, Del Mar Contreras M and Recio I (2011) Antihypertensive peptides: production, bioavailability and incorporation into foods. Advances in Colloid and Interface Science 165 23–35.
28. Hill C, Guarner F, Reid G et al. (2014) Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology 11 506–514.
29. Hong F, Ming L, Yi S, Zhanxia L, Yongquan W and Chi L (2008) The antihypertensive effect of peptides: a novel alternative to drugs? Peptides 29 1062–1071.
30. Jakobsen M and Narvhus J (1996) Yeasts and their possible beneficial and negative effects on the quality of dairy products. International Dairy Journal 6 755–768.
31. Jauhiainen T, Vapaatalo H, Poussa T, Kyrönpalo S, Rasmussen M and Korpela R (2005) Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. American Journal of Hypertension 18 1600–1605.
32. Kebede A, Viljoen B C, Gadaga T H, Narvhus J A and Lourens-Hattingh A (2007) The effect of container type on the growth of yeast and lactic acid bacteria during production of Sethemi, South African spontaneously fermented milk. Food Research International 40 33–38.
33. Korhonen H (2009) Milk-derived bioactive peptides: from science to applications. Journal of Functional Foods 1 177–187.
34. Kumar S, Singh S P, Mishra I M and Adhikari D K (2009) Ethanol and xylitol production from glucose and xylose at high temperature by kluyveromyces sp. Iipe453. Journal of Industrial Microbiology and Biotechnology 36 1483–1489. https://doi.org/10.1007/s10295-009-0636-6.
35. Kuwabara Y, Nagai S, Yoshimitsu N, Nakagawa I, Watanabe Y and Tamai Y (1995) Antihypertensive effect of the milk fermented by culturing with various lactic acid bacteria and a yeast. Journal of Fermentation and Bioengineering 80 294–295.
36. Lane M M and Morrissey J P (2010) Kluyveromyces marxianus: a yeast emerging from its sister's shadow. Fungal Biology Reviews 24 17–26.
37. Li Y, Sadiq F A, Liu T, Chen J and He G (2015) Purification and identification of novel peptides with inhibitory effect against angiotensin I-converting enzyme and optimization of process conditions in milk fermented with the yeast Kluyveromyces marxianus. Journal of Functional Foods 16 278–288.
38. Lönnerdal B and Iyer S (1995) Lactoferrin: molecular structure and biological function. Annual Review of Nutrition 15 93–110.
39. Löser C, Urit T, Keil P and Bley T (2015) Studies on the mechanism of synthesis of ethyl acetate in Kluyveromyces marxianus DSM 5422. Applied Microbiology and Biotechnology 99 1131–1144.
40. Maldonado Galdeano C, De Moreno De Leblanc A, Dogi C and Perdigón G (2010) Lactic acid bacteria as immunomodulators of the gut-associated immune system. In Biotechnology of Lactic Acid Bacteria, pp. 125–140. Centro de Referencia and San Miguel de Tucumán, eds. Argentina: Wiley-Blackwell.
41. Martinez-Maqueda D, Miralles B, Recio I and Hernandez-Ledesma B (2012) Antihypertensive peptides from food proteins: a review. Food & Function 3 350–361.
42. Martynova J, Kokina A, Kibilds J, Liepins J, Scerbaka R and Vigants A (2016) Effects of acetate on Kluyveromyces marxianus DSM 5422 growth and metabolism. Applied Microbiology and Biotechnology 100 4585–4594.
43. Matar C, Amiot J, Savoie L and Goulet J (1996) The effect of milk fermentation by Lactobacillus helveticus on the release of peptides during in vitro digestion. Journal of Dairy Science 79 971–979.
44. Narvhus J A and Gadaga T H (2003) The role of interaction between yeasts and lactic acid bacteria in African fermented milks: a review. International Journal of Food Microbiology 86 51–60.
45. Penner R, Fedorak R N and Madsen K L (2005) Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases. Current Opinion in Pharmacology 5 596–603.
46. Pihlanto A, Virtanen T and Korhonen H (2010) Angiotensin I converting enzyme (ACE) inhibitory activity and antihypertensive effect of fermented milk. International Dairy Journal 20 3–10.
47. Roostita R and Fleet G H (1996) Growth of yeasts in milk and associated changes to milk composition. International Journal of Food Microbiology 31 205–219.
48. Sansonetti S, Hobley T J, Curcio S, Villadsen J and Sin G (2013) Use of continuous lactose fermentation for ethanol production by Kluveromyces marxianus for verification and extension of a biochemically structured model. Bioresource Technology 130 703–709.
49. Saxelin M, Korpela R and Mäyrä-Mäkinen A (2003) 1 - Introduction: classifying functional dairy products. In Functional Dairy Products, pp. 1–16. Mattila-Sandholm T and Saarela M, eds.: Woodhead Publishing.
50. Sesoko S and Kaneko Y (1985) Cough associated with the use of captopril. Archives of Internal Medicine 145 1524.
51. Shihata A and Shah N P (2000) Proteolytic profiles of yogurt and probiotic bacteria. International Dairy Journal 10 401–408.
52. Tsai J-S, Chen T-J, Pan B S, Gong S-D and Chung M-Y (2008) Antihypertensive effect of bioactive peptides produced by protease-facilitated lactic acid fermentation of milk. Food Chemistry 106 552–558.
53. Unal G and Akalin A S (2012) Antioxidant and angiotensin-converting enzyme inhibitory activity of yoghurt fortified with sodium calcium caseinate or whey protein concentrate. Dairy Science and Technology 92 627–639.
54. Wang X, Wang L, Cheng X, Zhou J, Tang X and Mao X-Y (2012) Hypertension-attenuating effect of whey protein hydrolysate on spontaneously hypertensive rats. Food Chemistry 134 122–126.
55. Yadav J S S, Bezawada J, Ajila C M, Yan S, Tyagi R D and Surampalli R Y (2014) Mixed culture of kluyveromyces marxianus and candida krusei for single-cell protein production and organic load removal from whey. Bioresource Technology 164 119–127. https://doi.org/10.1016/j.biortech.2014.04.069.